Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Research

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-12-0213PMID 22869583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.

  2011cited by this paper
• Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

  2010cited by this paper
• Establishment and Characterization of a Novel Human Myeloma Cell Line, AMU-MM1, From a Multiple Myeloma Patient Involving Central Nerve System After Treatment with Bortezomib

  2010cited by this paper
• Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.

  2009cited by this paper
• International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

  2009cited by this paper
• Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.

  2009cited by this paper
• Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case

  2009cited by this paper
• Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA

  2008cited by this paper
• Characterization of MYC translocations in multiple myeloma cell lines.

  2008cited by this paper
• The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24

  2008cited by this paper
• Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer

  2008cited by this paper
• Identification of candidate tumour suppressor gene loci for Hodgkin and Reed‐Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines

  2008cited by this paper
• Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

  2007cited by this paper
• Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer

  2007cited by this paper
• Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

  2007cited by this paper
• Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes

  2007cited by this paper
• The PVT‐1 oncogene is a Myc protein target that is overexpressed in transformed cells

  2007cited by this paper
• Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

  2006cited by this paper
• Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.

  2006cited by this paper
• Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

  2006cited by this paper
• Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

  2006cited by this paper
• The neurobeachin gene spans the common fragile site FRA13A

  2005cited by this paper
• A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

  2005cited by this paper
• Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

  2004cited by this paper
• An opposing view on WWOX protein function as a tumor suppressor.

  2003cited by this paper
• Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma

  2003cited by this paper
• Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma

  2001cited by this paper
• Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.

  2001cited by this paper
• Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique.

  2001cited by this paper
• Neurobeachin: A Protein Kinase A-Anchoring,beige/Chediak-Higashi Protein Homolog Implicated in Neuronal Membrane Traffic

  2000cited by this paper
• WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

  2000cited by this paper
• Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

  2000cited by this paper
• Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome

  1999cited by this paper
• Identification and cloning of human G-protein gamma 7, down-regulated in pancreatic cancer.

  1998cited by this paper
• Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization

  1998cited by this paper
• Identification and Cloning of Human G-Protein γ 7, Down-regulated in Pancreatic Cancer

  1998cited by this paper
• The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.

  1997cited by this paper
• Cytogenetic findings in 200 patients with multiple myeloma.

  1995cited by this paper
• Translocations and amplification of the BCL2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome clones.

  1995cited by this paper
• Chimeric transcripts with an open reading frame are generated as a result of translocation to the Pvt‐1 region in mouse B‐cell tumors

  1994cited by this paper
• Localization of breakpoints by polymerase chain reactions in burkitt's lymphoma with 8;14 translocations

  1990cited by this paper
• Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3' of the myc gene, is rearranged in multiple myelomas.

  1990cited by this paper
• Effects of translocations on transcription from PVT

  1990cited by this paper
• Amplification of the c-myc and the pvt-like region in human multiple myeloma.

  1990cited by this paper
• Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations.

  1990cited by this paper
• Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc

  1989cited by this paper
• The PVT gene frequently amplifies with MYC in tumor cells

  1989cited by this paper
• Plasma cell karyotype in multiple myeloma.

  1988cited by this paper
• Plasma Cell Karyotype in Multiple Myeloma

  1988cited by this paper
• Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia.

  1988cited by this paper
• Analysis of G banded karyotypes in myeloma cells.

  1986cited by this paper
• Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas

  1986cited by this paper

• Extrachromosomal circular DNA: a potential clinical therapeutic target in malignant tumors.

  2026cites this paper
• LncRNA PVT1 in human cancers: genomic complexity, isoforms, functional elements, mechanism of action, subcellular localization and possible role as a therapeutic target

  2026cites this paper
• The multiplex crosstalk between non-coding RNAs, programmed cell death and related mechanisms: a dynamic duo in hematological malignancies

  2025cites this paper
• Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms.

  2025cites this paper
• B-cell–specific Wwox deletion promotes plasmablastic tumor development and proinflammatory signatures in myeloma model

  2025cites this paper
• Neurobeachin regulates hematopoietic progenitor differentiation and survival by modulating Notch activity

  2024cites this paper
• RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies

  2024cites this paper
• Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression

  2024cites this paper
• Long non-coding RNA PVT1 regulates TGF-β and promotes the proliferation, migration and invasion of hypopharyngeal carcinoma FaDu cells

  2024influential citation
• Cancer fusion transcripts with human non-coding RNAs

  2024cites this paper
• Long non-coding RNAs in non-small cell lung cancer: Implications for preventing therapeutic resistance.

  2023cites this paper
• Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer

  2023cites this paper
• Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma

  2023cites this paper
• Applications of noncoding ribonucleic acids in multiple myeloma patients

  2022cites this paper
• Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia

  2022cites this paper
• Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases

  2022cites this paper
• Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers

  2022cites this paper
• The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma

  2022cites this paper
• Small ring has big potential: insights into extrachromosomal DNA in cancer

  2021cites this paper
• An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells

  2021cites this paper
• Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma

  2021cites this paper
• Extra Chromosomal DNA in different cancers: individual genome with important biological functions.

  2021cites this paper
• 8q24.21 Locus: A Paradigm to Link Non-Coding RNAs, Genome Polymorphisms and Cancer

  2021cites this paper
• The Functions and Unique Features of LncRNAs in Cancer Development and Tumorigenesis

  2021cites this paper
• PVT1: a long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts.

  2021cites this paper
• Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell lymphoma

  2021cites this paper
• Long Noncoding RNA Plasmacytoma Variant Translocation 1 Is Increased in Multiple Myeloma and Correlates With Lower Induction Response

  2020cites this paper
• Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin

  2020cites this paper
• Long noncoding RNA PVT1: A highly dysregulated gene in malignancy

  2020cites this paper
• PVT1 Long Non-coding RNA in Gastrointestinal Cancer

  2020cites this paper
• p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.

  2020cites this paper
• Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis.

  2020cites this paper
• LncRNAs in Cancer: From garbage to Junk

  2020cites this paper
• The functions and clinical significance of circRNAs in hematological malignancies

  2020cites this paper
• Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression

  2020cites this paper
• Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells

  2020cites this paper
• Long non-coding RNAs and MYC association in hematological malignancies

  2020cites this paper
• MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review.

  2020cites this paper
• Long non-coding RNA T cell factor 7 is associated with increased disease risk and poor prognosis, and promotes cell proliferation, attenuates cell apoptosis and miR-200c expression in multiple myeloma

  2020cites this paper
• Tumorigenesis-Related Long Noncoding RNAs and Their Targeting as Therapeutic Approach in Cancer

  2020cites this paper
• Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma

  2019cites this paper
• Long Non-coding RNAs in the Development and Maintenance of Lymphoid Malignancies

  2019cites this paper
• Long Non-Coding RNA in the Pathogenesis of Cancers

  2019cites this paper
• Long Non-Coding RNAs in Multiple Myeloma

  2019cites this paper
• A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma

  2019cites this paper
• The role of long non‐coding RNAs in multiple myeloma

  2019cites this paper
• A Genome-wide Association Study in the Diabetic Patients Finds the 13q35.43-35.46 Locus Associated with Estimated Glomerular Filtration Rate: The Japan Multi-Institutional Collaborative Cohort Study

  2018cites this paper
• Identification of novel fusion transcripts in multiple myeloma

  2018cites this paper
• MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences

  2018cites this paper
• Therapeutic Targeting of Long Non-Coding RNAs in Cancer.

  2018cites this paper
• Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events

  2018cites this paper
• Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling

  2018influential citation
• miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer

  2018cites this paper
• Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

  2018cites this paper
• Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline.

  2018cites this paper
• NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K/AKT pathway.

  2018cites this paper
• WWOX, the FRA16D gene: A target of and a contributor to genomic instability

  2018cites this paper
• Emerging roles of noncoding RNAs in multiple myeloma: A review

  2018cites this paper
• Establishment and characterization of a novel vincristine‐resistant diffuse large B‐cell lymphoma cell line containing the 8q24 homogeneously staining region

  2018cites this paper
• Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a.

  2018cites this paper
• Genetic Variations of Long Noncoding RNAs in Cancer

  2018cites this paper
• WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response

  2017cites this paper
• Epigenetic repression of miR‐375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma

  2017cites this paper
• High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma

  2017cites this paper
• Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

  2017cites this paper
• MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences.

  2017cites this paper
• 3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations

  2017cites this paper
• Emerging roles for long noncoding RNAs in B-cell development and malignancy.

  2017cites this paper
• Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts

  2017cites this paper
• Long Noncoding RNAs in Lung Cancer.

  2016cites this paper
• Small-Molecule Targeting of BET Proteins in Cancer.

  2016influential citation
• Long noncoding RNA PVT1, a novel promising biomarker to predict lymph node metastasis and prognosis: a meta-analysis.

  2016cites this paper
• Long non-coding RNA PVT1 and cancer.

  2016cites this paper
• Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26

  2016cites this paper
• Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities

  2016cites this paper
• Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma

  2016cites this paper
• Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation

  2015cites this paper
• Recurrent Fusion Genes in Gastric Cancer : CLDN 18-ARHGAP 26 Induces Loss of Epithelial Integrity Graphical

  2015cites this paper
• Transcriptional dysregulation of the deleted in colorectal carcinoma gene in multiple myeloma and monoclonal gammopathy of undetermined significance

  2015cites this paper
• WWOX, large common fragile site genes, and cancer

  2015cites this paper
• The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains

  2015cites this paper
• Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer

  2015cites this paper
• WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

  2014cites this paper
• University of Groningen Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer L'Abbate,

  2014cites this paper
• Very large common fragile site genes and their potential role in cancer development

  2014cites this paper
• Chromosome 8q as the most frequent target for amplification in early gastric carcinoma

  2014cites this paper
• Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes

  2014cites this paper
• Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?

  2014cites this paper
• Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer.

  2014cites this paper
• Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

  2014cites this paper
• Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma

  2014cites this paper
• Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer

  2014cites this paper
• Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis

  2014cites this paper
• RSK2[Ser227] at N-terminal kinase domain is a potential therapeutic target for multiple myeloma

  2013cites this paper
• Instability at the FRA8I common fragile site disrupts the genomic integrity of the KIAA0146, CEBPD and PRKDC genes in colorectal cancer.

  2013cites this paper
• Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality

  2013cites this paper
• PVT1: A Cancer-associated Non-coding Gene Revisited

  2013cites this paper
• Long Non-Coding RNAs in Haematological Malignancies

  2013cites this paper
• Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms.

  2013cites this paper
• The BEACH Is Hot: A LYST of Emerging Roles for BEACH‐Domain Containing Proteins in Human Disease

  2013cites this paper